4th Quarter - Termination
W STRATEGIES, LLC for GLOBAL BLOOD THERAPEUTICS
Firm
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2022
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education about access to innovative sickle cell disease therapies and proposed legislation to increase funding and care coordination for patients with sickle cell disease. H.R.6216/S.4866 - Sickle Cell Disease Comprehensive Care Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DARREN WILLCOX | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.